Hjem
Ingfrid Salvesen Haldorsens bilde

Ingfrid Salvesen Haldorsen

Professor, Radiologist, Professor
  • E-postIngfrid.Haldorsen@uib.no
  • Telefon+47 954 04 470
  • Besøksadresse
    Dep. of Radiology
    Haukeland University Hospital
    5021 Bergen
    Rom 
    J-221 Sentralblokken, Haukeland Sykehus
  • Postadresse
    Postboks 7804
    5020 Bergen

Ingfrid Haldorsen er lege og spesialist i radiologi med lang klinisk erfaring innen abdominal- og gynekologisk radiologi. Hun disputerte i 2009 og har siden 2013 vært ansatt i bistilling som professor i radiologi ved UiB. Forskningsgruppen hennes Bergen Abdominal Imaging Research Group (www.uib.no/en/rg/abdimaging) jobber særlig med gynekologisk kreftavbildning (mmiv.no/cancerimaging/) og samarbeider tett med Bergen gynekologiske kreftforskningsgruppe ved Kvinneklinikken/UiB (www.uib.no/en/rg/gyncancer).

Vitenskapelig artikkel
  • 2020. Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. Clinical Radiology. 1-8.
  • 2020. Systematic approach for assessment of imaging features in chronic pancreatitis: a feasibility and validation study from the Scandinavian Baltic Pancreatic Club (SBPC) database. Abdominal Radiology. 1468-1480.
  • 2020. Secretin-stimulated magnetic resonance imaging reveals variable diagnostic accuracy according to etiology in pancreatic disease. Pancreas. 361-367.
  • 2020. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. European Radiology. 2443-2453.
  • 2020. Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. Cancers. 1-18.
  • 2020. Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiologica. 1-10.
  • 2020. High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. Gynecologic Oncology. 260-267.
  • 2020. Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. British Journal of Cancer. 1014-1022.
  • 2019. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. The Lancet Oncology. 795-805.
  • 2019. Poor outcome in hypoxic endometrial carcinoma is related to vascular density. British Journal of Cancer. 1037-1044.
  • 2019. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLOS ONE. 1-13.
  • 2019. Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study. BMC Cancer. 1-8.
  • 2019. Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. Gynecologic Oncology. 400-406.
  • 2019. Blood metabolites associate with prognosis in endometrial cancer. Metabolites. 1-15.
  • 2018. Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI. PLOS ONE. 1-16.
  • 2018. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. Journal of Magnetic Resonance Imaging. 1637-1647.
  • 2018. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiologica. 1010-1017.
  • 2018. Guidelines for the diagnostic cross sectional imaging and severity scoring of chronic pancreatitis. Pancreatology (Print). 764-773.
  • 2018. Good agreement between transabdominal and endoscopic ultrasound of the pancreas in chronic pancreatitis. Ultraschall in der Medizin. 1-9.
  • 2018. Development of an image-guided orthotopic xenograft mouse model of endometrial cancer with controllable estrogen exposure. International Journal of Molecular Sciences. 1-16.
  • 2018. Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries—Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology. Acta Obstetricia et Gynecologica Scandinavica. 1178-1184.
  • 2018. Blood steroids are associated with prognosis and fat distribution in endometrial cancer. Gynecologic Oncology. 46-52.
  • 2018. Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. BJOG: An International Journal of Obstetrics and Gynaecology. 1695-1703.
  • 2018. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial. European Radiology.
  • 2017. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. OncoTarget. 109018-109026.
  • 2017. The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort. Scandinavian Journal of Gastroenterology. 909-915.
  • 2017. Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging. European Radiology. 1495-1503.
  • 2017. Secretin-stimulated MRI characterization of pancreatic morphology and function in patients with chronic pancreatitis. Pancreatology (Print). 228-236.
  • 2017. Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. OncoTarget. 68530-68541.
  • 2017. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. Acta Radiologica. 497-505.
  • 2017. High visceral fat percentage is associated with poor outcome in endometrial cancer. OncoTarget. 105184-105195.
  • 2017. HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 378-387.
  • 2017. Diagnostic accuracy of transabdominal ultrasound in chronic pancreatitis. Ultrasound in Medicine and Biology. 735-743.
  • 2017. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. American Journal of Obstetrics and Gynecology. 432.e1-432.e17.
  • 2016. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. OncoTarget. 69844-69856.
  • 2016. Texture analysis of 2D spatial distribution of blood pharmacokinetic model parameters for endometrial carcinoma classification. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 91-96.
  • 2016. Single-session alcohol sclerotherapy of symptomatic liver cysts using 10-20 min of ethanol exposure: no recurrence at 2-16 years of follow-up. Abdominal Radiology. 1776-1781.
  • 2016. Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdominal Radiology. 1-10.
  • 2015. Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. Clinical Radiology. 487-494.
  • 2015. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. International Journal of Gynecological Cancer. 459-466.
  • 2015. Multimodal imaging of orthotopic mouse model of endometrial carcinoma. PLOS ONE. 11 sider.
  • 2015. Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. Journal of Nuclear Medicine. 1191-1198.
  • 2015. Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
  • 2015. Endorectal ultrasonography, strain elastography and MRI differentiation of rectal adenomas and adenocarcinomas. Colorectal Disease. 124-131.
  • 2014. Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. British Journal of Cancer. 107-114.
  • 2014. Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid. Diabetes. 259-269.
  • 2014. Assessment of Exocrine Pancreatic Function by Secretin-Stimulated Magnetic Resonance Cholangiopancreaticography and Diffusion-Weighted Imaging in Healthy Controls. Journal of Magnetic Resonance Imaging. 448-454.
  • 2013. Severe pancreatic dysfunction but compensated nutritional status in monogenic pancreatic disease caused by carboxyl-ester lipase mutations. Pancreas. 1078-1084.
  • 2013. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. American Journal of Human Genetics. 150-157.
  • 2013. Exocrine pancreatic function in hepatocyte nuclear factor 1 beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabetic Medicine. 946-955.
  • 2013. Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. European Radiology. 2916-2925.
  • 2012. Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. European Radiology. 1601-1611.
  • 2012. Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecologic Oncology. 413-418.
  • 2012. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatric Diabetes. e1-e5.
  • 2011. The role of pancreatic imaging in monogenic diabetes. Nature Reviews Endocrinology.
  • 2011. Double reading of radiological examinations in Norway. Acta Radiologica. 516-521.
  • 2011. Central nervous system lymphoma: Characteristic findings on traditional and advanced imaging. American Journal of Neuroradiology. 984-992.
  • 2009. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. American Journal of Neuroradiology. 744-751.
  • 2008. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. Journal of Clinical Endocrinology and Metabolism. 3505-3509.
  • 2008. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabetic Medicine. 782-787.
  • 2008. AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer. 8 sider.
  • 2007. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-Ester lipase. Diabetes. 444-449.
  • 2007. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 - Time trends in a 15-year national survey. Cancer. 1803-1814.
  • 2006. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics. 54-62.
Vitenskapelig foredrag
  • 2019. Early Performance Measures Among Women Screened with DBT after a Prior DBT or a Prior DM, in a National Screening Program.
  • 2015. Preoperative tumor texture at MRI predicts deep myometrial invasion and non-endometrioid subtype in endometrial carcinomas.
  • 2014. Functional imaging for individualized cancer treatment.
  • 2011. Modest agreement between radiologists on pelvic MR imaging findings in endometrial carcinomas.
Vitenskapelig antologi/Konferanseserie
  • 2015. Innovation in Imaging & Vizualization. The MedViz Conference 2015. Allkopi Forlag.
Populærvitenskapelig artikkel
  • 2011. Bildediagnostikk av pankreas ved monogen diabetes. Diabetesforum. 20-22.
Doktorgradsavhandling
  • 2017. Molecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment.
  • 2016. Functional imaging to promote individualized and targeted therapy in endometrial cancer.
  • 2009. Primary central nervous system lymphoma in Norway 1989-2003.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • 2015. Rosemont score from transabdominal ultrasound in chronic pancreatitis. 3 sider.
  • 2012. Epidemiology of Primary Central Nervous System Lymphoma. 9 sider.
Sammendrag/abstract
  • 2013. Value of preoperative 2-deoxy-2-[18F]fluoroglucose positron emission tomography/computer tomography (FDG-PET/CT) in endometrial carcinomas. Acta Radiologica. 13-13.
  • 2013. Assessment of exocrine pancreatic funtion by secretin-stimulated MRCP and DWI in healthy controls and in patients with monogenic diabetes. Acta Radiologica. 13-13.
Poster
  • 2018. Research Agenda of the Mohn Medical Imaging and Visualization Centre in Bergen, Norway.
  • 2015. Secretin stimulated MRCP in the evaluation of exocrine pancreatic function in cystic fibrosis.
  • 2015. Rosemont score from transabdominal ultrasound in chronic pancreatitis.
  • 2014. Metabolic tumor volume on FDG-PET/CT predicts deep myometrial invasion, lymph node metastases and survival in patients with endometrial carcinoma .
Vitenskapelig oversiktsartikkel/review
  • 2019. What is the role of imaging at primary diagnostic work-up in uterine cervical cancer? 1-15.
  • 2019. Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. 1-16.
  • 2019. Diagnostic accuracy of clinical biomarkers for preoperative prediction of lymph node metastasis in endometrial carcinoma: A systematic review and meta-analysis. e880-e890.
  • 2016. What is the best breoperative imaging for endometrial cancer? 1-11.
  • 2016. Secretin-Stimulated Magnetic Resonance Imaging Assessment of the Benign Pancreatic Disorders: Systematic Review and Proposal for a Standardized Protocol. 1092-1103.
  • 2016. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature. 879-885.
  • 2012. The role of pancreatic imaging in monogenic diabetes mellitus. 148-159.
  • 2012. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. 2-12.
  • 2012. Markers for individualised therapy in endometrial carcinoma. E353-E361.
Fagartikkel
  • 2011. Erfaringer fra en teleradiologisk klinikk i India. Noraforum : tidsskrift for radiologi. 24-26.

Se fullstendig oversikt over publikasjoner i CRIStin.

  1. Løkeland T, Nygård AB, Salbu HR, Salvesen I, Skei S, Varugmese K, Oksne VI, Haug K. Establishing smoking habits among adolescents. A study of 9th grade students. Tidsskr Nor Lægeforenin 1993; 113: 3259-3261.
  2. Haldorsen IS, Larsen JL: How are radiographic examinations documented in medical records? Tidsskr Nor Lægeforenin 2000; 120: 3424-3426.
  3. Haldorsen IS, Aarseth JH, Hollender A, Larsen JL, Espeland A, Mella O: Incidence, Clinical Features, Treatment and Outcome of Primary Central Nervous System Lymphoma in Norway.  A Ten-year National Survey. Acta Oncol 2004; 43:520-529.
  4. Haldorsen IS, Espeland A, Larsen JL, Mella O: Diagnostic delay in primary central nervous system lymphoma. Acta Oncol 2005; 44:728-734.
  5. Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V et al.: Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 2006; 38:54-62.
  6. Raeder H, Haldorsen IS, Ersland L, Grüner R, Taxt T, Søvik O. et al.: Pancreatic Lipomatosis Is a Structural Marker in Nondiabetic Children With Mutations in Carboxyl-Ester Lipase. Diabetes 2007; 56:444-449.
  7. Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A: Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003. Time trends in a fifteen-year national survey. Cancer 2007; 110:1803-14.
  8. Haldorsen IS, Kråkenes J, Goplen AK, Dunlop O, Mella O, Espeland A: AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer 2008, 8:225.
  9. Vesterhus M, Haldorsen IS, Raeder H, Molven A, Njølstad PR: Reduced Pancreatic Volume in HNF1A-MODY. J Clin Endocrinol Metab 2008; 93:3505-3509.
  10. Haldorsen IS, Vesterhus M, Raeder H, Jensen DK, Søvik O, Molven A, Njølstad PR et al.: Lack of Pancreatic Body and Tail in HNF1B Mutation Carriers. Diabet Med 2008; 25:782-787.
  11. Haldorsen IS, Kråkenes J, Krossnes BK, Mella O, Espeland A: CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 2009; 30:744-751. 
  12. Haldorsen IS, Espeland A, Larsson E-M: Nervous System (CNS) Lymphoma – Characteristic Findings on Traditional and Advanced imaging. AJNR Am J Neuroradiol, 2011; 32:984-92.
  13. Husby JA, Espeland A, Kalyanpur A, Brocker C, Haldorsen IS: Double Reading of Radiological Examinations in Norway. ACTA Radiologica 2011; 52:516-21.
  14. Haldorsen IS, Salvesen HB: Staging of Endometrial Carcinomas with MRI using traditional and novel MRI Techniques. Clinical Radiology 2012; 67:2-12.
  15. Gonç EN, Ozturk BB, Haldorsen IS, Molnes J, Immervoll H, Ræder H, Molven A, Søvik O, Njølstad PR: HNF1B mutation in a Turkish Child with Renal and Exocrine Pancreas Insufficiency, Diabetes and Liver Disease. Pediatr Diabetes 2012; 13 (2):e1-5.
  16. Haldorsen IS, Ræder H, Vesterhus M, Molven A, Njølstad P: Pancreatic Imaging in Monogenic Diabetes. Nature Reviews Endocrinology 2012; 8:148-159.
  17. Haldorsen IS, Husby J, Werner H, Magnussen IJ, Rørvik J, Helland H, Trovik J, Salvesen ØO, Espeland A, Salvesen HB: MR imaging of endometrial carcinomas: modest agreement between radiologists. European Radiology 2012, 22:1601-1611.
  18. Salvesen HB, Haldorsen IS, Trovik J: Markers for individualized therapy in endometrial carcinoma. Lancet Oncol 2012;13:e353-61.
  19. Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen ØO, Trovik J, Salvesen HB: Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecol Oncol. 2012; 126:413-8.
  20. Tjora E, Wathle G, Engjom T, Erchinger F, Molven A, Aksnes L, Haldorsen IS, Dimcevski G, Njølstad PR,  Ræder H. Severely reduced pancreatic function but compensated nutritional status in a monogenic pancreatic disease caused by CEL mutations. Pancreas, 2013; 42:1078-84.
  21. Tjora E, Wathle G, Erchinger F, Engjom T, Molven A, Aksnes L, Haldorsen IS, Dimcevski G, Ræder H, Njølstad P. Exocrine pancreatic function in HNF1B-MODY is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabetic Medicine, 2013; 30:946-55.
  22. Haldorsen IS, Grüner ER, Husby, JA, Magnussen IJ, Werner HMJ, Salvesen ØO, Bjørge L, Stefansson I, Akslen L, Trovik J, Taxt T, Salvesen HB. Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients with increased risk of recurrence. Eur Radiol 2013; 23:2916-25.
  23. Chudasama K, Winnay J, Johansson S, Claudi T, König R, Haldorsen IS, Johansson B, Woo JR, Aarskog D, Sagen J, Kahn C, Molven A,  Njølstad PR. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling.  Am J Hum Genet 2013; 93:150-7.
  24. Wathle G, Tjora E, Ersland L, Dimcevski G, Molven A, Njølstad PR, Haldorsen IS: Assessment of exocrine pancreatic function by secretin stimulated MRCP and DWI in healthy controls. J Magn Reson Imaging 2014; 39:259-69.
  25. Raeder H, Mc Allister FE, Tjora E, Bhatt S, Haldorsen IS, Hu J, Willems SM, Vesterhus M, ElQuamaari A, Liu M, Raeder MTB, Immervoll H, Hoem D, Dimcevski G, Njolstad PR, Molven A, Gygi SP, Kulkarni RN: Carboxyl-ester lipase Maturity-Onset Diabetes of the Young is Associated with Development of Pancreatic Cysts and Upregulated MAPK Signaling in Secretin-stimulated duodenal fluid. Diabetes 2014; 63:259-69.
  26. Haldorsen IS, Stefansson I, Grüner ER, Husby JA, Magnussen IJ, Werner HMJ, Salvesen ØO, Bjørge L, Trovik J, Taxt, T, Akslen L, Salvesen HB. Tumor blood flow at DCE-MRI is negatively correlated to microvascular proliferation in endometrial carcinoma. British Journal of Cancer 2014; 110:107-14
  27. Waage JER, Leh S, Bach S, Røsler C, Pfeffer F, Havre RF, Haldorsen IS, Ødegaard S, Baatrup G. Endorectal elastography staging of rectal tumours may improve the selection of patients for organ sparing treatment. Colorectal Disease 2014; doi: 10.1111.
  28. Husby J, Salvesen ØO, Magnussen IJ, Trovik J, Bjørge L, Salvesen HB, Haldorsen IS. Tumor apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumor volume in endometrial carcinomas. Clinical Radiology 2015; 70:487-94.
  29. Ytre-Hauge S, Husby JA, Magnussen IJ, Salvesen ØO, Bjørge L, Trovik J, Stefansson I, Salvesen HB, Haldorsen IS. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases and patient outcome in endometrial carcinomas. Int J Gynecol Cancer 2015; 25:459-66.
  30. Stefansson IM, Ræder M, Wik E, Mannelqvist M, Kusonmano K, Knutsvik G, Haldorsen IS, Øyan AM, Kalland KH, Staff AC, Salvesen HB, Akslen LA. Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. Oncotarget  2015.
  31. Husby J, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS. Metabolic tumor volume (MTV) at 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18-FDG-PET/CT) improves preoperative identification of high-risk endometrial carcinoma patients. J of Nuclear Medicine  2015; 56:1191-8.
  32. Haldorsen IS, Popa M, Fonnes T, Brekke N, Kopperud R, Visser NCM, Rygh CB, Pavlin T, Salvesen HB, McCormack E, Krakstad C. Multimodal imaging of orthotopic mouse model of endometrial carcinoma. PLoS One, 2015.
  33. Bollineni VR, Ytre-Hauge S, Balabay OB, Salvesen HB, Haldorsen IS. High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature. J of Nuclear Medicine 2016.
  34. Berg A, Fasmer KE, Mauland KK, Ytre-Hauge S, Hoivik  EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, Bjørge L, Bjørnerud A, Salvesen HB, Werner HMJ, Krakstad C, Haldorsen IS.  Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. Oncotarget 2016.
  35. Madzak A, Olesen SS, Wathle G, Haldorsen IS, Drewes AM Frøkjær JB. Secretin stimulated magnetic resonance imaging of benign pancreatic disorders – systematic review and proposal for a standardized protocol. Pancreas 2016 (May 11).
  36. Haldorsen IS, Salvesen HB. What is the best preoperative imaging for endometrial cancer? Current Oncology Reports, 2016; 18:25.
  37. Larssen TB, Viste A, Horn A, Haldorsen IS, Espeland A. Single-session alcohol sclerotherapy of symptomatic liver cysts using 10-20 minutes of ethanol exposure: no recurrence at 2-16 years follow up. Abdominal Radiology (NY) 2016; 41(9):1776-81.    
  38. Kociński M, Materka A, Lundervold A, Salvesen H, Ytre-Hauge S, Haldorsen I. Texture analysis of 2D spatial distribution of blood pharamcokinetic model parameters for endometrial carcinoma classification. IEEE Explore, 2016.
  39. Madzak A, Engjom T, Wathle GK, Olesen SS, Tjora E, Njølstad PR, Lærum BN, Drewes AM, Dimcevski G, Frøkjær JB, Haldorsen IS. Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdominal Radiology (NY) 2016 (Nov 10).  
  40. Engjom T, Havre R, Erchinger F, Pham K, Haldorsen IS, Gilja OH, Dimcevski G. Diagnostic accuracy of transabdominal ultrasound in chronic pancreatitis. Ultrasound in medicine and biology, Jan 17, 2017.
  41. Madzak A, Olesen SS, Haldorsen IS, Drewes AM, Frøkjær JB. Secretin-stimulated MRI characterization of pancreatic morphology and function in patients with chronic pancreatitis. Pancreatology Jan27, 2017.
  42. Olesen S, Poulsen JL, Drewes AM, Frøkjær JB, Laukkarinen J, Parhiala M, Petersen IR, Novovic S, Lindkvist B, Dimcevski G, Engjom T, Erchinger F, Haldorsen IS, Pukitis, A, Ozola- Zālīte I, Haas S, Vujasinovic M, Löhr M, Bulinas A, Jensen NM, Jørgensen MT, Nøjgaard, C. The Scandinavian Baltic Pancreatic Club (SBPC) Database: Design, Rationale and Characterisation of the Study Cohort. Scandinavian Journal of Gastroenterology, May 4, 2017.

 

 

 

 

 

 

 

Book chapters:

 

1.      Haldorsen IS & O’Neill B. Epidemiology of Primary Central Nervous System Lymphoma, Lymphoma and Leukemia of the Nervous System, Batchelor, Tracy; DeAngelis, Lisa M. (Eds.) pp. 89-97. Springer 2011. ISBN: 978-1-4419-7667-3.

 

2.       Søvik O, Sagen J, Haldorsen IS, Tjora E, Njølstad PR. HNF1B-MODY: A disorder of development with diabetes and congenital malformations in pancreas and urogenital tract due to mutations in HNF1B. In: Inborn Errors of Development (Epstein, Erickson and Wynshaw-Boris, eds). Oxford University Press, New York 2013. 

 

Selected reviews and popular science publications in Norwegian:

 

1. MR av pankreas hos barn med arvelig diabetes. Noraforum 2006; 3:21-23.

 

2. Radiologiske funn ved AIDS-relatert primært hjernelymfom i Norge. Noraforum 2007; 4:32.

 

3. Primary Central Nervous System Lymphoma in Norway, 1989-2003. Noraforum 2009; 2:19.

 

4. Bildediagnostikk av pankreas ved monogen diabetes. Diabetesforum 2011; 4: 20-22.

 

5. Erfaringer fra en teleradiologisk klinikk i India. Noraforum 2011; 3: 24-26.

 

6. Skandinaviske og japanske radiologer møtes i Finland. Noraforum 2014; 2: 12.